|
|
||||||||
Medical and Chemistry Departments Brookhaven National Laboratory, Upton, New York
Departments of Psychiatry and Medicine, Division of Geriatrics, SUNY-Stony Brook, Stony Brook, New York
Department of Psychiatry, New York University, New York, New York
Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania
Correspondence: For correspondence or reprints contact: Nora D. Volkow, MD, Medical Department, Brookhaven National Laboratory, Upton, NY 11973.
ABSTRACT
Postmortem studies have documented degeneration of dopamine cells with age, but the changes that occur in healthy aging individuals is less clear. The purpose of this study was to evaluate the extent to which age-induced changes in dopamine transporters occur in subjects with no evidence of motor impairment. Methods: We evaluated 23 right-handed healthy volunteers (age range 20–74 yr) using PET and [11C]d-threo-methylphenidate. The ratio of the distribution volume for [11C]d-threo-methylphenidate in striatum to that in cerebellum was used as model parameter for dopamine transporter availability (Bmax/Kd + 1). Results: Dopamine transporter availability, was significantly lower in subjects >40 yr of age than in those <40 yr. Estimates of dopamine transporter availability showed a significant negative correlation with age both for the putamen (r = –0.72, p < 0.0001) and the caudate (r = –0.74, p < 0.0001). Dopamine transporter availability was higher in the left than in the right putamen but did not differ between the left and right caudate. Conclusion: This study documents a 6.6% decrease per decade of life in striatal dopamine transporters of healthy volunteers.
Key Words: PET dopamine transporters degeneration
This article has been cited by other articles:
![]() |
S. M. Landau, R. Lal, J. P. O'Neil, S. Baker, and W. J. Jagust Striatal Dopamine and Working Memory Cereb Cortex, June 11, 2008; (2008) bhn095v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Diamond Consequences of Variations in Genes that affect Dopamine in Prefrontal Cortex Cereb Cortex, September 1, 2007; 17(suppl_1): i161 - i170. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Vandenberghe and J Tournoy Cognitive aging and Alzheimer's disease Postgrad. Med. J., June 1, 2005; 81(956): 343 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. van Dyck, R. T. Malison, L. K. Jacobsen, J. P. Seibyl, J. K. Staley, M. Laruelle, R. M. Baldwin, R. B. Innis, and J. Gelernter Increased Dopamine Transporter Availability Associated with the 9-Repeat Allele of the SLC6A3 Gene J. Nucl. Med., May 1, 2005; 46(5): 745 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Ribeiro, M. Vidailhet, C. Loc'h, C. Dupel, J. P. Nguyen, M. Ponchant, F. Dolle, M. Peschanski, P. Hantraye, P. Cesaro, et al. Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease Arch Neurol, April 1, 2002; 59(4): 580 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.S. Mattay, F. Fera, A. Tessitore, A.R. Hariri, S. Das, J.H. Callicott, and D.R. Weinberger Neurophysiological correlates of age-related changes in human motor function Neurology, February 26, 2002; 58(4): 630 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. van Dyck, J. P. Seibyl, R. T. Malison, M. Laruelle, S. S. Zoghbi, R. M. Baldwin, and R. B. Innis Age-Related Decline in Dopamine Transporters: Analysis of Striatal Subregions, Nonlinear Effects, and Hemispheric Asymmetries Am J Geriatr Psychiatry, February 1, 2002; 10(1): 36 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, D. Franceschi, M. Sedler, S. J. Gatley, E. Miller, R. Hitzemann, Y.-S. Ding, et al. Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence J. Neurosci., December 1, 2001; 21(23): 9414 - 9418. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sekine, M. Iyo, Y. Ouchi, T. Matsunaga, H. Tsukada, H. Okada, E. Yoshikawa, M. Futatsubashi, N. Takei, and N. Mori Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET Am J Psychiatry, August 1, 2001; 158(8): 1206 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. J. Laine, A. Ahonen, P. Rasanen, T. Pohjalainen, J. Tiihonen, and J. Hietala The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics Alcohol Alcohol., May 1, 2001; 36(3): 262 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, M. Leonido-Yee, D. Franceschi, M. J. Sedler, S. J. Gatley, R. Hitzemann, Y.-S. Ding, et al. Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers Am J Psychiatry, March 1, 2001; 158(3): 377 - 382. [Abstract] [Full Text] |
||||
![]() |
L. K. Jacobsen, J. K. Staley, R. T. Malison, S. S. Zoghbi, J. P. Seibyl, T. R. Kosten, and R. B. Innis Elevated Central Serotonin Transporter Binding Availability in Acutely Abstinent Cocaine-Dependent Patients Am J Psychiatry, July 1, 2000; 157(7): 1134 - 1140. [Abstract] [Full Text] |
||||
![]() |
N. D. Volkow, J. Logan, J. S. Fowler, G.-J. Wang, R. C. Gur, C. Wong, C. Felder, S. J. Gatley, Y.-S. Ding, R. Hitzemann, et al. Association Between Age-Related Decline in Brain Dopamine Activity and Impairment in Frontal and Cingulate Metabolism Am J Psychiatry, January 1, 2000; 157(1): 75 - 80. [Abstract] [Full Text] |
||||
![]() |
C. C. Meltzer Neuropharmacology and Receptor Studies in the Elderly J Geriatr Psychiatry Neurol, October 1, 1999; 12(3): 137 - 149. [Abstract] [PDF] |
||||
![]() |
G. Esposito, B. S. Kirkby, J. D. Van Horn, T. M. Ellmore, and K. F. Berman Context-dependent, neural system-specific neurophysiological concomitants of ageing: mapping PET correlates during cognitive activation Brain, May 1, 1999; 122(5): 963 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ilgin, J. Zubieta, S. G. Reich, R. F. Dannals, H. T. Ravert, and J. J. Frost PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease Neurology, April 1, 1999; 52(6): 1221 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Jeon, J M Kim, J M Jeong, K M Kim, Y S Chang, D S Lee, and M C Lee Dopamine transporter imaging with [123I]-beta -CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 60 - 64. [Abstract] [Full Text] |
||||
![]() |
N. D. Volkow, R. C. Gur, G.-J. Wang, J. S. Fowler, P. J. Moberg, Y.-S. Ding, R. Hitzemann, G. Smith, and J. Logan Association Between Decline in Brain Dopamine Activity With Age and Cognitive and Motor Impairment in Healthy Individuals Am J Psychiatry, March 1, 1998; 155(3): 344 - 349. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |